Gene editing of Calpain3 in LGMD2A iPS cells for the dev

Project: Research project

Description

Gene editing of Calpain3 in LGMD2A iPS cells for the development of autologous cell therapy
StatusFinished
Effective start/end date8/1/1710/31/18

Funding

  • COALITION TO CURE CALPAIN 3, INC.

Fingerprint

Cell- and Tissue-Based Therapy
Gene Editing
Limb-girdle muscular dystrophy type 2A